Equilibrium Dialysis LC-MS/MS Service for Protein & Tissue Binding

Equilibrium dialysis combined with Mass Spectrometry (ED-MS) is the foundational method for measuring how much of a drug remains free and active in the bloodstream or within specific organs. When a drug enters a biological system, it naturally binds to proteins in the plasma or tissues. However, only the "free" or unbound portion of the drug can cross cell membranes, interact with therapeutic targets, and drive biological efficacy.

Equilibrium dialysis measures this critical "fraction unbound" (fu) by placing a biological sample (like plasma) and a clean buffer solution into two separate chambers, divided by a semi-permeable membrane. Over time, only the free, unbound drug molecules can pass through the membrane's microscopic pores. Once the concentration of free drug stabilizes equally on both sides—a state known as thermodynamic equilibrium—we extract the buffer and use highly sensitive LC-MS/MS to precisely quantify the free drug concentration. Because this is a label-free, true physiological simulation, it provides the most accurate and reliable binding data available in early drug discovery.

Every drug discovery team eventually encounters the "sticky" compound problem. As medicinal chemists design more complex, highly lipophilic (fat-soluble) molecules to hit challenging targets, these compounds tend to stick to everything—plastic tubes, assay plates, and filtration membranes. In standard assays, this Non-Specific Binding (NSB) leads to artificially low recovery rates, skewed binding data, and ultimately, incorrect dosing predictions. When hydrophobic interactions dominate, standard screening methods simply cannot be trusted.

We understand how frustrating it is to synthesize a promising analog, only to have the data ruined by poor assay methodology. At Creative Proteomics, our ADME and pharmacokinetics team specializes in rescuing these difficult projects. We utilize the industry-leading Rapid Equilibrium Dialysis (RED) format, utilizing 96-well plates equipped with specialized low-binding regenerated cellulose membranes. This high-throughput setup minimizes the surface area-to-volume ratio where drugs can get trapped, significantly reducing NSB risks while maximizing sample recovery. By closely monitoring the thermodynamics of the system, we ensure that your compound remains in the solution phase where it belongs.

Furthermore, accurately calculating the fu of a drug that is >99% bound requires extreme analytical sensitivity, because the amount of free drug floating in the buffer chamber is minuscule. Our platform leverages state-of-the-art QQQ and Q-TOF mass spectrometers, allowing us to accurately detect and quantify trace levels of your compound that other laboratories might miss entirely. If your project is still in the earliest stages of hit identification and you need to screen thousands of compounds before optimizing for ADME properties, you can also explore our high-throughput Affinity Selection Mass Spectrometry (ASMS) solutions to rapidly filter your initial compound libraries.

Translational success requires understanding drug distribution beyond just the bloodstream. Different tissues express different proteins, which drastically alters local drug binding. To support a complete pharmacokinetic profile, our Equilibrium Dialysis LC-MS/MS service covers a comprehensive range of biological matrices.

• Plasma Protein Binding (PPB): The standard starting point for understanding systemic drug exposure across various animal models. Essential for calculating safety margins and initial dosage models.
• Tissue Binding (Brain, Liver, Lung): Critical for understanding whether your drug is actually penetrating the blood-brain barrier or accumulating in target organs. Brain homogenate binding (fu,brain) is particularly vital for central nervous system (CNS) therapeutics.
• Microsomal Binding: Essential for determining the fraction of unbound drug available for metabolic enzymes in the liver, ensuring accurate intrinsic clearance (CLint) and hepatic extraction ratio calculations.

Choosing the right in vitro binding assay can save months of wasted optimization time and thousands of dollars in misdirected synthesis. While other methods exist, they each come with distinct physiological and physical limitations that can derail a preclinical program. Here is how Equilibrium Dialysis stacks up against alternative approaches.